Proprietary market intelligence for healthcare launches — built from years of systematic analysis of leading pharma launches in regulated markets.
"Market knowledge distilled from real practice — not from literature. The Prediction Model is the result of years of observing how pharma launches actually work: which mechanisms land, which fail, and why."
No generic market overview. A structured analysis of the questions that actually matter before a launch or a positioning decision.
Which communication mechanisms are realistically deployable in your therapeutic area — and which are already occupied by competitors, regulatorily problematic, or demonstrably ineffective?
Where does your product stand against the competition? Where are the real differentiation opportunities — and where do you need to defend, because competitors are already strategically well-positioned?
Prioritized recommendations: what to do, what to avoid, and why. Decision-ready, without management-summary overhead.
The Prediction Model is the result of years of systematic analysis of leading pharma launches — across multiple therapeutic areas and competitive situations. It makes visible which communication strategies hold up in regulated markets — and which fail.
Ready-made intelligence dossiers on current pharma product launches — in two depths: Starter and Professional. Available for immediate purchase and use.
Structured analysis of communication mechanisms, competitive positioning, and strategic action options in the ESR1-SERD market.
Structured analysis of communication mechanisms, competitive positioning, and strategic action options for IPF and PPF.
Structured analysis of communication mechanisms, competitive positioning, and strategic action options in the BoNT market.
No matching dossier in the catalog? I create a custom intelligence analysis for your product — deeper, tailored to your specific question.
You're approaching the market launch of a healthcare product and want to know: which mechanisms are realistic? How strong is your competitive position? What should you prioritize?
A new competitor is entering your therapeutic area. You need a structured analysis of the newcomer's likely communication strategies — and a response to it.
You have an innovative product but no access to systematic market intelligence. The Prediction Model delivers structured decision foundations without an internal research apparatus.
The Prediction Model does not deliver market sizes, epidemiology data, or payer analysis. It analyzes communication patterns, mechanisms, and strategic options — based on real launch experience.
The framework considers the regulatory context (HWG, AMG, AMNOG) as a boundary condition — but does not replace legal or regulatory expert advice.
The Prediction Model works with what is already clinically and regulatorily established — it assesses marketing options based on the given data situation.
A short description of your product / therapeutic area is enough — I'll come back with an initial assessment.